ClinicalTrials.gg
CompletedNCT06702930Updated Nov 27, 2024

Exercise Timing on the Morning Blood Pressure Surge

An interventional study of Morning high-intensity interval exercise and Evening high-intensity interval exercise in Post-Exercise Hypotension, Ambulatory Blood Pressure Monitoring and High-intensity Interval Exercise, sponsored by University of Guelph. Completed at 1 site in Canada. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-11-27.

Sponsored by University of Guelph · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 4 years 9 months after the study started (first participant enrolled Jan 2020, registered Nov 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
31
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Study summary

The goal of this clinical trial was to assess the effects of morning vs. evening high-intensity interval exercise on the magnitude of the morning blood pressure surge in young healthy adults. The main questions it aimed to answer were:

  • Does the timing of high-intensity interval exercise modulate the magnitude of the morning blood pressure surge?
  • Do sex differences exist?

Participants came in and completed a bout of high-intensity interval exercise in the morning (8-10 am) and evening (5-7 pm) as well as a no exercise control, and ambulatory blood pressure was assessed for 24 hours afterwards.

Read the detailed description

Introductory Visit:

Participants came in for 4 visits. The first visit was an introductory visit where chronotype, eligibility for exercise, and anthropometrics were measured. This was followed by a maximal incremental exercise test to determine aerobic capacity (i.e., V̇O2peak) on a cycle ergometer, and instrumentation of an ambulatory blood pressure monitor for familiarization during daily activities and sleep.

Intervention Visits:

Three intervention visits (control, morning exercise, and evening exercise) were completed. The order was randomized using and each visit was separated by a minimum of 36 hours. Each intervention visit began by obtaining the participant's resting blood pressure and heart rate and ended with the instrumentation of the ambulatory blood pressure monitor. No exercise was performed during the control visit. The morning exercise visit included a bout of high-intensity interval exercise between 8-10 am and the evening exercise visit included a bout of high-intensity interval exercise between 5-7 pm. The high-intensity interval exercise protocol consisted of a light intensity, 3-minute warm-up at 15% peak power followed by ten 1-minute work intervals at 80% of peak power, with each interval separated by 1-minute rest intervals at 15% peak power. A 3-minute cool down was performed at 15% peak power.

02

Conditions studied

  • Post-Exercise Hypotension
  • Ambulatory Blood Pressure Monitoring
  • High-intensity Interval Exercise

Keywords

  • Ambulatory blood pressure monitoring
  • Morning blood pressure surge
  • High-intensity interval exercise
  • Post-exercise hypotension
03

In context

Post-Exercise Hypotension

22 studies on the registry are indexed under Post-Exercise Hypotension; 2 are open to participants now.

This study's enrollment of 31 is above the median of 21 across 22 interventional studies indexed under Post-Exercise Hypotension.

Browse Post-Exercise Hypotension studies →

Lead sponsor

University of Guelph is the lead sponsor of 70 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Between 18-50 years of age.
  • No history of known disease.
  • None smokers.
  • No use of chronic medications other than oral .

Exclusion criteria

Exclusion:

  • \<18 years of age.
  • >50 years of age.
  • Cardiovascular disease.
  • Metabolic disease.
  • History of smoking (within the past 3 months).
  • Chronic medications (other than oral ).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
31 participants (actual)

Study arms

  • No intervention
    Control

    No exercise was performed and ambulatory blood pressure was assessed for 24 hours.

  • Experimental
    Morning high-intensity interval exercise

    High-intensity interval exercise was performed between 8-10 am and ambulatory blood pressure was assessed for 24 hours after.

    Other: Morning high-intensity interval exercise

  • Experimental
    Evening high-intensity interval exercise

    High-intensity interval exercise was performed between 5-7 pm and ambulatory blood pressure was assessed for 24 hours after.

    Other: Evening high-intensity interval exercise

Interventions

  • OtherMorning high-intensity interval exercise

    High-intensity interval exercise was performed between 8-10 am

  • OtherEvening high-intensity interval exercise

    High-intensity interval exercise was performed between 5-7 pm

06

What researchers measure

Primary outcomes

  1. Morning blood pressure surge

    The difference between morning blood pressure (the mean of the 4 blood pressure readings after awakening) and sleep-trough blood pressure (the mean of the lowest blood pressure during sleep and two adjacent blood pressure readings).

    Time frame: Through study completion, an average of 4 weeks.

Secondary outcomes

  1. Nighttime blood pressure dip

    The percent difference between daytime blood pressure (average of all blood pressure readings when participants reported being awake) and nighttime blood pressure (average of all blood pressure readings when the participant reported being asleep).

    Time frame: Through study completion, an average of 4 weeks.

07

Study locations

1 site
  • University of Guelph
    Guelph, Ontario N1G 2W1, Canada
08

References and documents

Individual participant data

Plan to share: Yes — Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).

Supporting information: Study protocol

Time frame: After publication; unending.

Access criteria: Investigators whose proposed use of the data has been approved by an independent review committee ("learned intermediary") identified for this purpose.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 27, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06702930
Lead sponsor
University of Guelph
Responsible party
Philip Millar (Associate Professor, University of Guelph) — Principal investigator
First posted
Nov 25, 2024
Start date
Jan 28, 2020
Primary completion
Jun 8, 2023
Completion
Jun 8, 2023
Last update
Nov 27, 2024

Study contacts

Julian Bommarito, MSc
study director · University of Guelph
Philip Millar, PhD
principal investigator · University of Guelph

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion